Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection

Insights

Smooth-muscle antibodies (SMA) are frequently detected in patients with cytomegalovirus (CMV) infection, particularly in early disease stages. These antibodies, mainly IgM, decrease faster than CMV antibodies, suggesting a role in CMV immune response.

Area of Science:

  • Immunology
  • Virology
  • Autoimmunity

Background:

  • Cytomegalovirus (CMV) infection is common and can elicit various immune responses.
  • The presence and significance of autoantibodies during viral infections are of clinical interest.

Purpose of the Study:

  • To investigate the association between smooth-muscle antibodies (SMA) and cytomegalovirus (CMV) infection.
  • To characterize the immunoglobulin classes and temporal dynamics of SMA in CMV-infected patients.

Main Methods:

  • Sera from 63 CMV antibody-positive patients and 40 CMV antibody-negative donors were tested for SMA.
  • Immunoglobulin classes (IgG, IgM, IgA) of SMA were analyzed.
  • Anti-nuclear antibodies (ANA) and other autoantibodies were also assessed.

Main Results:

  • SMA were detected in 16% of CMV-positive patients versus 0% of controls (P = 0.005).
  • SMA were primarily IgG and IgM, with IgM predominant in early CMV infection and decreasing faster than CMV antibodies.
  • ANA were more frequent in CMV-positive sera, often co-occurring with SMA.

Conclusions:

  • SMA are significantly associated with CMV infection, particularly in the early phase.
  • The presence of SMA, especially IgM, may serve as an indicator of acute or recent CMV infection.
  • Further research is warranted to elucidate the precise role of SMA in the immunopathogenesis of CMV.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...